Schedule 13G Filing by Millennium Management and Affiliates for Quoin Pharmaceuticals Ltd.

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 9.0% of the Ordinary Shares of Quoin Pharmaceuticals Ltd. The filing, dated October 24, 2025, indicates that the shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander. The total number of shares beneficially owned is 1,901,585, representing 9.0% of the outstanding Ordinary Shares. The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.